Logo image of CGX.CA

CINEPLEX INC (CGX.CA) Stock Fundamental Analysis

Canada - Toronto Stock Exchange - TSX:CGX - CA1724541000 - Common Stock

12.39 CAD
-0.04 (-0.32%)
Last: 11/28/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CGX. CGX was compared to 10 industry peers in the Entertainment industry. CGX has a medium profitability rating, but doesn't score so well on its financial health evaluation. CGX has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year CGX has reported negative net income.
In the past year CGX had a positive cash flow from operations.
In multiple years CGX reported negative net income over the last 5 years.
CGX had a positive operating cash flow in 4 of the past 5 years.
CGX.CA Yearly Net Income VS EBIT VS OCF VS FCFCGX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

1.2 Ratios

CGX's Return On Assets of -1.58% is fine compared to the rest of the industry. CGX outperforms 70.00% of its industry peers.
The Return On Invested Capital of CGX (4.16%) is better than 80.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CGX is in line with the industry average of 5.05%.
The 3 year average ROIC (3.36%) for CGX is below the current ROIC(4.16%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -1.58%
ROE N/A
ROIC 4.16%
ROA(3y)1.91%
ROA(5y)-6.6%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)3.36%
ROIC(5y)N/A
CGX.CA Yearly ROA, ROE, ROICCGX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K -2.5K

1.3 Margins

With a decent Operating Margin value of 7.31%, CGX is doing good in the industry, outperforming 80.00% of the companies in the same industry.
In the last couple of years the Operating Margin of CGX has declined.
With an excellent Gross Margin value of 66.88%, CGX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Gross Margin of CGX has remained more or less at the same level.
Industry RankSector Rank
OM 7.31%
PM (TTM) N/A
GM 66.88%
OM growth 3YN/A
OM growth 5Y-3.58%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.02%
GM growth 5Y0.37%
CGX.CA Yearly Profit, Operating, Gross MarginsCGX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CGX is destroying value.
The number of shares outstanding for CGX has been reduced compared to 1 year ago.
The number of shares outstanding for CGX remains at a similar level compared to 5 years ago.
Compared to 1 year ago, CGX has an improved debt to assets ratio.
CGX.CA Yearly Shares OutstandingCGX.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CGX.CA Yearly Total Debt VS Total AssetsCGX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 0.16, we must say that CGX is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.16, CGX perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
The Debt to FCF ratio of CGX is 17.31, which is on the high side as it means it would take CGX, 17.31 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CGX (17.31) is better than 70.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 17.31
Altman-Z 0.16
ROIC/WACC0.55
WACC7.54%
CGX.CA Yearly LT Debt VS Equity VS FCFCGX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

CGX has a Current Ratio of 0.48. This is a bad value and indicates that CGX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of CGX (0.48) is worse than 70.00% of its industry peers.
A Quick Ratio of 0.45 indicates that CGX may have some problems paying its short term obligations.
CGX has a Quick ratio of 0.45. This is amonst the worse of the industry: CGX underperforms 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.48
Quick Ratio 0.45
CGX.CA Yearly Current Assets VS Current LiabilitesCGX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 38.64% over the past year.
Looking at the last year, CGX shows a quite strong growth in Revenue. The Revenue has grown by 18.50% in the last year.
CGX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.39% yearly.
EPS 1Y (TTM)38.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%105.13%
Revenue 1Y (TTM)18.5%
Revenue growth 3Y26.54%
Revenue growth 5Y-4.39%
Sales Q2Q%-11.8%

3.2 Future

The Earnings Per Share is expected to grow by 48.90% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 3.62% on average over the next years.
EPS Next Y94.86%
EPS Next 2Y77.96%
EPS Next 3Y48.9%
EPS Next 5YN/A
Revenue Next Year3.9%
Revenue Next 2Y4.43%
Revenue Next 3Y3.62%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CGX.CA Yearly Revenue VS EstimatesCGX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
CGX.CA Yearly EPS VS EstimatesCGX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -2 -4 -6

5

4. Valuation

4.1 Price/Earnings Ratio

CGX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 18.00, CGX is valued on the expensive side.
70.00% of the companies in the same industry are more expensive than CGX, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of CGX to the average of the S&P500 Index (36.56), we can say CGX is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 18
CGX.CA Price Earnings VS Forward Price EarningsCGX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 30

4.2 Price Multiples

70.00% of the companies in the same industry are more expensive than CGX, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, CGX is valued a bit cheaper than the industry average as 70.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 7.51
EV/EBITDA 9.8
CGX.CA Per share dataCGX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

CGX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CGX's earnings are expected to grow with 48.90% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y77.96%
EPS Next 3Y48.9%

0

5. Dividend

5.1 Amount

CGX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CINEPLEX INC

TSX:CGX (11/28/2025, 7:00:00 PM)

12.39

-0.04 (-0.32%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)11-06 2025-11-06/bmo
Earnings (Next)02-09 2026-02-09/amc
Inst Owners30%
Inst Owner ChangeN/A
Ins Owners1.97%
Ins Owner ChangeN/A
Market Cap786.02M
Revenue(TTM)1.34B
Net Income(TTM)-34.27M
Analysts76
Price Target14.54 (17.35%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-121.38%
Min EPS beat(2)-153.04%
Max EPS beat(2)-89.71%
EPS beat(4)0
Avg EPS beat(4)-89.71%
Min EPS beat(4)-153.04%
Max EPS beat(4)-29.05%
EPS beat(8)2
Avg EPS beat(8)-685.37%
EPS beat(12)4
Avg EPS beat(12)-451.06%
EPS beat(16)6
Avg EPS beat(16)-314.31%
Revenue beat(2)1
Avg Revenue beat(2)-4.34%
Min Revenue beat(2)-8.87%
Max Revenue beat(2)0.2%
Revenue beat(4)1
Avg Revenue beat(4)-4.66%
Min Revenue beat(4)-8.87%
Max Revenue beat(4)0.2%
Revenue beat(8)3
Avg Revenue beat(8)-4.11%
Revenue beat(12)7
Avg Revenue beat(12)-1.75%
Revenue beat(16)10
Avg Revenue beat(16)-0.99%
PT rev (1m)10.89%
PT rev (3m)14.09%
EPS NQ rev (1m)-12.16%
EPS NQ rev (3m)-15.22%
EPS NY rev (1m)-122.5%
EPS NY rev (3m)-122.73%
Revenue NQ rev (1m)-1.79%
Revenue NQ rev (3m)-4.93%
Revenue NY rev (1m)-0.63%
Revenue NY rev (3m)-1.88%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 18
P/S 0.59
P/FCF 7.51
P/OCF 4.75
P/B N/A
P/tB N/A
EV/EBITDA 9.8
EPS(TTM)-0.54
EYN/A
EPS(NY)0.69
Fwd EY5.56%
FCF(TTM)1.65
FCFY13.32%
OCF(TTM)2.61
OCFY21.05%
SpS21.09
BVpS-1.15
TBVpS-11.47
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.58%
ROE N/A
ROCE 5.77%
ROIC 4.16%
ROICexc 4.25%
ROICexgc 7.04%
OM 7.31%
PM (TTM) N/A
GM 66.88%
FCFM 7.82%
ROA(3y)1.91%
ROA(5y)-6.6%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)3.36%
ROIC(5y)N/A
ROICexc(3y)3.46%
ROICexc(5y)N/A
ROICexgc(3y)5.89%
ROICexgc(5y)N/A
ROCE(3y)4.66%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y2.1%
ROICexc growth 3YN/A
ROICexc growth 5Y0.06%
OM growth 3YN/A
OM growth 5Y-3.58%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.02%
GM growth 5Y0.37%
F-Score8
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 17.31
Debt/EBITDA 6.66
Cap/Depr 37.25%
Cap/Sales 4.55%
Interest Coverage 0.73
Cash Conversion 63.37%
Profit Quality N/A
Current Ratio 0.48
Quick Ratio 0.45
Altman-Z 0.16
F-Score8
WACC7.54%
ROIC/WACC0.55
Cap/Depr(3y)39.73%
Cap/Depr(5y)33.4%
Cap/Sales(3y)5.83%
Cap/Sales(5y)8.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)38.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%105.13%
EPS Next Y94.86%
EPS Next 2Y77.96%
EPS Next 3Y48.9%
EPS Next 5YN/A
Revenue 1Y (TTM)18.5%
Revenue growth 3Y26.54%
Revenue growth 5Y-4.39%
Sales Q2Q%-11.8%
Revenue Next Year3.9%
Revenue Next 2Y4.43%
Revenue Next 3Y3.62%
Revenue Next 5YN/A
EBIT growth 1Y126.94%
EBIT growth 3YN/A
EBIT growth 5Y-7.81%
EBIT Next Year205.17%
EBIT Next 3Y54.92%
EBIT Next 5Y27.47%
FCF growth 1Y-13.68%
FCF growth 3Y41.4%
FCF growth 5Y-13.75%
OCF growth 1Y-17.53%
OCF growth 3Y38.48%
OCF growth 5Y-12.79%

CINEPLEX INC / CGX.CA FAQ

What is the ChartMill fundamental rating of CINEPLEX INC (CGX.CA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CGX.CA.


What is the valuation status of CINEPLEX INC (CGX.CA) stock?

ChartMill assigns a valuation rating of 5 / 10 to CINEPLEX INC (CGX.CA). This can be considered as Fairly Valued.


How profitable is CINEPLEX INC (CGX.CA) stock?

CINEPLEX INC (CGX.CA) has a profitability rating of 4 / 10.


Can you provide the financial health for CGX stock?

The financial health rating of CINEPLEX INC (CGX.CA) is 2 / 10.


Is the dividend of CINEPLEX INC sustainable?

The dividend rating of CINEPLEX INC (CGX.CA) is 0 / 10 and the dividend payout ratio is 0%.